Today 2026.05.06 D-End
Today 
|
Satellite Symposium 1 Sep. 12 (Fri), 08:30-09:00 |
Room C (2F) |
|
|---|---|---|
| Chair(s) | Seok Lee (Ewha Womans University College of Medicine) | |
Ponatinib and Chemotherapy for Adult Patients with Newly Diagnosed Ph+ ALL Based on the PhALLCON Trial
Chinese Academy of Medical Sciences, China
|
Satellite Symposium 2 Sep. 12 (Fri), 08:30-09:00 |
Room D (2F) |
|
|---|---|---|
| Chair(s) | Kyoo-Hyung Lee (Ewha Womans University College of Medicine) | |
Real-World Treatment Patterns and Outcomes with Oral Azacitidine Maintenance Therapy in Patients with Acute Myeloid Leukemia
University Health Network, Canada
|
Oral Presentation 5 |
Room A (1F) |
||
|---|---|---|---|
| Date & Time | Sep. 12 (Fri), 09:00-10:00 | ||
| Chair(s) |
Ho Sup Lee (Kosin University College of Medicine) Yoon Seok Choi (Korea University College of Medicine) |
||
| Speaker(s) | 09:00-09:10 | Nespecabtagene Autoleucel (AT101) Demonstrates High Efficacy in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Interim Results of a Phase 2 Study Dok Hyun Yoon (University of Ulsan College of Medicine) | |
| 09:10-09:20 | Real-World Clinical Outcomes of Tisagenlecleucel in Relapsed or Refractory DLBCL: A Single-Center Retrospective Study Gi June Min (College of Medicine, The Catholic University of Korea) | ||
| 09:20-09:30 | Real-World Outcomes of Tisagenlecleucel versus Reduced-intensity Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Large B-cell Lymphomas Tong-Yoon Kim (College of Medicine, The Catholic University of Korea) | ||
| 09:30-09:40 | High-Risk Extranodal NK/T-Cell Lymphoma Patients Could Benefit More from Allogeneic Hematopoietic Stem Cell Transplantation as Consolidation: A Real-World Multicenter Analysis in China Yi Xia (Peking University People's Hospital) | ||
| 09:40-09:50 | Outcomes of Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Analysis from the Taiwan Blood and Marrow Transplantation Registry Po-Tsen Liu (College of Medicine, National Cheng Kung University) | ||
| 09:50-10:00 | Frequency, Characteristics, Management, and Outcomes of Posttransplant Lymphoproliferative Disorders after Allogeneic HSCT in Children, 15 Years Experience: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group Fatih Erbey (Koc University School of Medicine) | ||
|
Oral Presentation 6 |
Room B (1F) |
||
|---|---|---|---|
| Date & Time | Sep. 12 (Fri), 09:00-10:00 | ||
| Chair(s) |
Min Kyoung Kim (Yeungnam University College of Medicine) Seong Hyun Jeong (Ajou University School of Medicine) |
||
| Speaker(s) | 09:00-09:10 | Impact of Donor Age on Survival Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome Dong Hyun Kim (Seoul National University College of Medicine) | |
| 09:10-09:20 | Long-Term Outcomes and Prognostic Factors Following Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myelodysplastic Syndrome: A Nationwide Population-Based Study in Korea Eun Sang Yi (Korea University College of Medicine) | ||
| 09:20-09:30 | Impact of Letermovir Prophylaxis on the Pattern of CMV Events and Its Association with Relapse in Allogenic HSCT Recipients for Myelodysplastic Syndromes Sin Young Park (Seoul National University Hospital) | ||
| 09:30-09:40 | Impact of Pre-Transplant Cytoreductive Therapy on Post-Transplant Outcomes in Patients with Myelodysplastic Syndromes with Excess of Blasts: A Retrospective Analysis Yu-eun Lee (University of Ulsan College of Medicine) | ||
| 09:40-09:50 | Incidence and Risk Factors for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis Yu-Qian Sun (Peking University People's Hospital) | ||
| 09:50-10:00 | Association between Splenomegaly and Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis Patients So Yeon Park (College of Medicine, The Catholic University of Korea) | ||
|
Oral Presentation 7 |
Room C (2F) |
||
|---|---|---|---|
| Date & Time | Sep. 12 (Fri), 09:00-10:00 | ||
| Chair(s) |
Kyoung Ha Kim (Soonchunhyang University College of Medicine) Ho-Young Yhim (Jeonbuk National University Medical School) |
||
| Speaker(s) | 09:00-09:10 | The Efficacy of Combination Treatment with All-Trans Retinoic Acid, Bortezomib, and Natural Killer cells on CD44-Overexpressing Myeloma Van-Tan Nguyen (Chonnam National University Medical School) | |
| 09:10-09:20 | Preclinical Study of IL-15 Armored Chimeric Antigen Receptor - Natural Killer Cells for Multiple Myeloma Ga-Young Song (Chonnam National University Medical School) | ||
| 09:20-09:30 | Automated, Computational Interpretation of Multiparametric Flow Cytometry Based-Minimal Residual Disease for Multiple Myeloma (CAREMM-2401 Study) Ka Young Kim (College of Medicine, The Catholic University of Korea) | ||
| 09:30-09:40 | Cost-Effectiveness of Expanding Autologous Stem Cell Transplantation Eligibility to Patients Aged 65 to 70 Years with Multiple Myeloma: A Nationwide Cohort Study in Korea Suein Choi (College of Medicine, The Catholic University of Korea) | ||
| 09:40-09:50 | Retrospective Analysis of Medical Costs and Length of Initial Hospitalization Following Allogeneic Hematopoietic Stem Cell Transplantation Ayako Takarada (University of Tsukuba) | ||
| 09:50-10:00 | Improving Pre-Admission Readiness for HSCT Patients: Outcomes of a Structured Nursing-Led Quality Improvement Program Pei-Yu Lo (Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation) | ||
|
Oral Presentation 8 |
Room D (2F) |
||
|---|---|---|---|
| Date & Time | Sep. 12 (Fri), 09:00-10:00 | ||
| Chair(s) |
Eun Sun Yoo (Ewha Womans University College of Medicine) Hye Lim Jung (Sungkyunkwan University School of Medicine) |
||
| Speaker(s) | 09:00-09:10 | Impact of Oral and Gut Microbiome Dysbiosis on Treatment Complications in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Suejung Jo (College of Medicine, The Catholic University of Korea) | |
| 09:10-09:20 | Hematopoietic Stem Cell Transplantation for Congenital Dyserythropoietic Anemia Jeong A Park (Inha University College of Medicine) | ||
| 09:20-09:30 | Quadruple Immunotherapy for Paediatric Patients with Relapsed or Refractory Neuroblastoma Pamela Lee (The University of Hong Kong) | ||
| 09:30-09:40 | Busulfan–Melphalan versus Carboplatin–Etoposide–Melphalan as High-Dose Chemotherapy for High-Risk Neuroblastoma in Taiwan: A Single-Center Retrospective Study Chiao-Yu Cheng (National Taiwan University Children's Hospital) | ||
| 09:40-09:50 | Outcomes of Salvage Treatment Including High-Dose Chemotherapy and Autologous Stem Cell Transplantation of Recurrent Central Nervous System Germ Cell Tumors Suhyun Yoon (University of Ulsan College of Medicine) | ||
| 09:50-10:00 | Treatment Outcomes of Medulloblastoma: Efficacy of Reduced-Dose Radiotherapy, Intrathecal Methotrexate, and Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation Hee Won Cho (Sungkyunkwan University School of Medicine) | ||
|
Joint Symposium 3 (East Asia Collaborative Session) Sep. 12 (Fri), 10:10-11:50 |
Room A (1F) |
|
|---|---|---|
| Chair(s) |
Je-Jung Lee (Chonnam National University Medical School) Chi-Cheng Li (Hualien Tzu Chi Hospital) |
|
Optimizing Autologous Stem Cell Transplantation in the Age of CAR T-cell Therapy: Still a Standard?
Hanyang University College of Medicine, Korea
Treatment Options after CAR T-cell Failure in Diffuse Large B-cell Lymphoma
National Cancer Center Hospital, Japan
Clinical Practice and System Innovation of CAR T-Cell Therapy
Tongji Hospital Affiliated to Tongji University, China
Immune Reconstitution after CAR T-cell Therapy vs. Stem Cell Transplantation: Mechanistic Insights and Clinical Implications
National Taiwan University Hospital, Taiwan
|
Scientific Session 5 Sep. 12 (Fri), 10:10-11:40 |
Room B (1F) |
|
|---|---|---|
| Chair(s) |
Kyung-Mi Lee (Korea University College of Medicine) Hyoung Jin Kang (Seoul National University College of Medicine) |
|
Enhancing CAR-T Cell Function through Membrane-Anchored Cytokines
Curocell Inc., Korea
The Mechanism of Immune Synapse Formation and Its Application to Synapse-Fortified CAR T Cells
Seoul National University College of Medicine, Korea
From Bench to Bedside: The Promise of Engineered NK Cell Therapy
The University of Texas MD Anderson Cancer Center, USA
|
Scientific Session 6 Sep. 12 (Fri), 10:10-11:40 |
Room C (2F) |
|
|---|---|---|
| Chair(s) |
Hyeoung-Joon Kim (Chonnam National University Medical School) Hoon Kook (Chonnam National University Medical School) |
|
Clinical Approach of GvHD Bronchiolitis Obliterans Syndrome - Early Detection, Diagnosis, Treatment
Fred Hutchinson Cancer Center, USA
Novel Therapeutic Options in Chronic GVHD
Dana-Farber Cancer Institute, USA
FDA-approved Therapies for Chronic GVHD
University Medical Center Freiburg, Germany
|
Education Session 2 Sep. 12 (Fri), 10:10-11:40 |
Room D (2F) |
|
|---|---|---|
| Chair(s) |
Hawk Kim (Ewha Womans University College of Medicine) Byung Sik Cho (College of Medicine, The Catholic University of Korea) |
|
Medical Research and Scientific Writing Using AI
CHA University, Korea
Scientific Writing in BMT and Cellular Therapy Research
Saint-Antoine Hospital, France
HSCT Research Using Easy R (EZR) Focusing on Survival Analysis
Jichi Medical University, Japan
|
Luncheon Symposium 5 Sep. 12 (Fri), 12:00-12:40 |
Room A (1F) |
|
|---|---|---|
| Chair(s) | Jun Ho Jang (Sungkyunkwan University School of Medicine) | |
Optimizing Fabhalta Therapy: Strategies and Best Practices in PNH Patients
King's College Hospital NHS Foundation Trust, UK
|
Luncheon Symposium 6 Sep. 12 (Fri), 12:00-12:40 |
Room B (1F) |
|
|---|---|---|
| Chair(s) | Je-Hwan Lee (University of Ulsan College of Medicine) | |
Optimising Transplant Potential in older AML Patients: Insights from Real-World Data
University Hospital Essen, Germany
|
Luncheon Symposium 7 Sep. 12 (Fri), 12:00-12:40 |
Room C (2F) |
|
|---|---|---|
| Chair(s) | Seok Jin Kim (Sungkyunkwan University School of Medicine) | |
Optimizing Neutropenia Management in Lymphoma Patients: Clinical Insights and Future Directions of G-CSF Therapy
College of Medicine, The Catholic University of Korea, Korea
|
Luncheon Symposium 8 Sep. 12 (Fri), 12:00-12:40 |
Room D (2F) |
|
|---|---|---|
| Chair(s) | Yeung-Chul Mun (Ewha Womans University College of Medicine) | |
An Update on the Efficacy and Safety Profile of 200-day Prevymis Therapy and Q&A
Peter MacCallum Cancer Centre, Australia
|
Scientific Session 7 Sep. 12 (Fri), 13:00-14:30 |
Room A (1F) |
|
|---|---|---|
| Chair(s) |
Ho-Jin Shin (Pusan National University School of Medicine) Sung-Yong Kim (Konkuk University School of Medicine) |
|
Maintenance Therapy after Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia
The University of Texas MD Anderson Cancer Center, USA
Role of MRD Monitoring and Maintenance Therapy after HSCT in TP53 altered AML or MDS
H. Lee Moffitt Cancer Center & Research Institute, USA
Donor Lymphocyte Infusion Strategy: Korean Institutional Perspective
College of Medicine, The Catholic University of Korea, Korea
|
Scientific Session 8 Sep. 12 (Fri), 13:00-14:30 |
Room B (1F) |
|
|---|---|---|
| Chair(s) |
Hyeon Jin Park (National Cancer Center) Jae Wook Lee (College of Medicine, The Catholic University of Korea) |
|
CAR T Cell Therapies for Pediatric Solid Tumors
IRCCS Bambino Gesù Children's Hospital, Italy
The Optimal Conditioning for Allo-HSCT in Children with ALL (FORUM Trial)
Wroclaw Medical University, Poland
Management of Post-HSCT Relapse in Pediatric Leukemia
College of Medicine, The Catholic University of Korea, Korea
|
Nursing Session 1 Sep. 12 (Fri), 13:00-14:30 |
Room C (2F) |
|
|---|---|---|
| Chair(s) | EunJung Joo (National Cancer Center) | |
Optimizing Endocrine Outcomes after Hematopoietic Stem Cell Transplantation
Yonsei University College of Medicine, Korea
Acute Kidney Injury after Hematopoietic Stem Cell Transplantation
Sungkyunkwan University School of Medicine, Korea
Psychosocial Distress in Hematopoietic Stem Cell Transplantation
The Cyber University of Korea, Korea
|
Education Session 3 Sep. 12 (Fri), 13:00-14:30 |
Room D (2F) |
|
|---|---|---|
| Chair(s) |
Deog-Yeon Jo (Chungnam National University College of Medicine) Sung-Hyun Kim (Dong-A University College of Medicine) |
|
Intensity of Conditioning Regimen (Evolution of Conditioning Regimen)
Korea University College of Medicine, Korea
Advances in GVHD Prophylaxis: From ATG to Post-Transplant Cyclophosphamide (PTCy)
Kyungpook National University School of Medicine, Korea
Second Malignancy after HSCT
College of Medicine, The Catholic University of Korea, Korea
|
Presidential Symposium Sep. 12 (Fri), 14:40-15:20 |
Room A (1F) |
|
|---|---|---|
| Chair(s) | Ho Joon Im (University of Ulsan College of Medicine) | |
AML-Specific Therapeutics: Integrating Risk-Stratified Transplantation and Immunotherapeutic Targeting
Fred Hutchinson Cancer Center, USA
|
Plenary Session 3 Sep. 12 (Fri), 15:20-16:00 |
Room A (1F) |
|
|---|---|---|
| Chair(s) | Seong Kyu Park (Soonchunhyang University College of Medicine) | |
Personalized Conditioning Strategies in Allogeneic HSCT: Balancing Disease Control and Toxicity Across Age Groups
Saint-Antoine Hospital, France
|
Debate Session 1 Sep. 12 (Fri), 16:40-17:30 |
Room A (1F) |
|
|---|---|---|
| Chair(s) | Sung Hwa Bae (Daegu Catholic University School of Medicine) | |
Necessity
Chungnam National University College of Medicine, Korea
Risk
University of Ulsan College of Medicine, Korea
Debate
University of Ulsan College of Medicine, Korea
|
Debate Session 2 Sep. 12 (Fri), 17:30-18:20 |
Room A (1F) |
|
|---|---|---|
| Chair(s) | Kyung-Nam Koh (University of Ulsan College of Medicine) | |
Haploidentical
University of Ulsan College of Medicine, Korea
Alternative Unrelated Donors (including Cord Blood)
Seoul National University College of Medicine, Korea
Debate
Seoul National University College of Medicine, Korea
|
Joint Symposium 4 (JSTCT-KSBMT) Sep. 12 (Fri), 16:40-18:20 |
Room C (2F) |
|
|---|---|---|
| Chair(s) |
Seong Kyu Park (Soonchunhyang University College of Medicine) Takanori Teshima (Hokkaido University) |
|
Defining MRD Response Through LSC Detection: A TIM-3–Based Flow Cytometric Perspective
Kyushu University Hospital, Japan
Transplantation & Management of High-risk ALL with Poor MRD Response
National Cancer Center Hospital, Japan
Integrating Flow Cytometry-Based MRD into Transplant and Maintenance Strategies in MM
College of Medicine, The Catholic University of Korea, Korea
Transplantation & Management of High-risk MM with Poor MRD Response
Seoul National University Hospital, Korea
|
Education Session 4 Sep. 12 (Fri), 16:40-18:10 |
Room D (2F) |
|
|---|---|---|
| Chair(s) | Jun Eun Park (Korea University College of Medicine) | |
Infection Prophylaxis in CAR T-Cell Therapy
Dong-A University College of Medicine, Korea
Should a Well-Cooked Diet Be Recommended for Transplant Patients?
Hospital de la Santa Creu i Sant Pau, Spain
Viral Infection after HSCT
Chonnam National University Medical School, Korea
